Xeris Biopharma Ownership 2024 | Who Owns Xeris Biopharma Now?
Institutional Ownership
43.06%
Insider Ownership
3.91%
Retail Ownership
53.03%
Institutional Holders
135.00
Xeris Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 7.35% | 0.00% | 10,332,078 | 371,572 | 3.73% | 23,247,175 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.45% | 0.00% | 7,656,890 | 50,648 | 0.67% | 17,228,002 | Jun 30, 2024 |
| CAXTON CORP | 3.64% | 58.31% | 5,113,348 | - | - | 11,505,033 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 3.44% | 1.69% | 4,830,526 | 664,030 | 15.94% | 10,868,684 | Jun 30, 2024 |
| STATE STREET CORP | 2.32% | 0.00% | 3,258,633 | 43,617 | 1.36% | 7,331,924,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.31% | 0.00% | 3,240,379 | 195,015 | 6.40% | 7,292,316 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 2.22% | 5.40% | 3,120,170 | 300,000 | 10.64% | 7,020,382 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.21% | 0.00% | 1,696,524 | 771 | 0.05% | 3,817,179 | Jun 30, 2024 |
| MORGAN STANLEY | 1.15% | 0.00% | 1,609,924 | 318,966 | 24.71% | 3,622,330 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 1.04% | 0.20% | 1,465,875 | -77,998 | -5.05% | 3,298,219 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.96% | 0.01% | 1,351,640 | 342,300 | 33.91% | 3,041,192 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.96% | 0.00% | 1,342,612 | -247,890 | -15.59% | 3,020,877 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.85% | 0.00% | 1,193,080 | 52,074 | 4.56% | 2,684,430 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.79% | 0.00% | 1,107,169 | -52,386 | -4.52% | 2,491,131,000 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 0.74% | 0.14% | 1,046,587 | - | - | 2,354,821 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.58% | 0.74% | 820,000 | 220,000 | 36.67% | 1,845,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.46% | 0.00% | 641,666 | 13,619 | 2.17% | 1,443,748 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.45% | 0.00% | 636,244 | 215,757 | 51.31% | 1,431,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.43% | 0.10% | 605,663 | 593,952 | 5071.74% | 1,363,000 | Jun 30, 2024 |
| INVENOMIC CAPITAL MANAGEMENT LP | 0.42% | 0.06% | 592,078 | -12,434 | -2.06% | 1,332,176 | Jun 30, 2024 |
Xeris Biopharma's largest institutional shareholder is BLACKROCK INC., holding 7.35% of the company's total share outstanding, currently valued at $23.25M. The top 10 institutional shareholders own together 30.12% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAXTON CORP | 3.64% | 58.31% | 5,113,348 | - | - | 11,505,033 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 2.22% | 5.40% | 3,120,170 | 300,000 | 10.64% | 7,020,382 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 3.44% | 1.69% | 4,830,526 | 664,030 | 15.94% | 10,868,684 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.58% | 0.74% | 820,000 | 220,000 | 36.67% | 1,845,000 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 1.04% | 0.20% | 1,465,875 | -77,998 | -5.05% | 3,298,219 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 0.74% | 0.14% | 1,046,587 | - | - | 2,354,821 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.21% | 0.12% | 300,000 | - | - | 675,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.43% | 0.10% | 605,663 | 593,952 | 5071.74% | 1,363,000 | Jun 30, 2024 |
| INVENOMIC CAPITAL MANAGEMENT LP | 0.42% | 0.06% | 592,078 | -12,434 | -2.06% | 1,332,176 | Jun 30, 2024 |
| POWELL INVESTMENT ADVISORS, LLC | 0.04% | 0.06% | 50,000 | 50,000 | 100.00% | 112,500 | Jun 30, 2024 |
| STONERIDGE INVESTMENT PARTNERS LLC | 0.04% | 0.05% | 53,211 | - | - | 120,000 | Jun 30, 2024 |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 0.12% | 0.03% | 170,937 | 19,542 | 12.91% | 382,899 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.07% | 0.03% | 100,830 | 154 | 0.15% | 226,868 | Jun 30, 2024 |
| IHT WEALTH MANAGEMENT, LLC | 0.21% | 0.02% | 296,335 | -2,032 | -0.68% | 666,771 | Jun 30, 2024 |
| LJI WEALTH MANAGEMENT, LLC | 0.03% | 0.02% | 48,050 | -3,400 | -6.61% | 108,113 | Jun 30, 2024 |
| GPS WEALTH STRATEGIES GROUP, LLC | 0.04% | 0.02% | 62,025 | - | - | 139,556 | Jun 30, 2024 |
| QUARRY LP | 0.02% | 0.02% | 30,000 | 500 | 1.69% | 67,500 | Jun 30, 2024 |
| VEERY CAPITAL, LLC | 0.01% | 0.01% | 14,163 | - | - | 31,867 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.04% | 0.01% | 62,083 | - | - | 139,687 | Jun 30, 2024 |
| DIVERSIFIED TRUST CO | 0.13% | 0.01% | 175,739 | -2 | -0.00% | 395,412 | Jun 30, 2024 |
The largest Xeris Biopharma shareholder by % of total assets is CAXTON CORP. The company owns 5.11M shares of Xeris Biopharma (XERS), representing 58.31% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 3.44% | 1.69% | 4,830,526 | 664,030 | 15.94% | 10,868,684 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.43% | 0.10% | 605,663 | 593,952 | 5071.74% | 1,363,000 | Jun 30, 2024 |
| BLACKROCK INC. | 7.35% | 0.00% | 10,332,078 | 371,572 | 3.73% | 23,247,175 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.96% | 0.01% | 1,351,640 | 342,300 | 33.91% | 3,041,192 | Jun 30, 2024 |
| MORGAN STANLEY | 1.15% | 0.00% | 1,609,924 | 318,966 | 24.71% | 3,622,330 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 2.22% | 5.40% | 3,120,170 | 300,000 | 10.64% | 7,020,382 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.58% | 0.74% | 820,000 | 220,000 | 36.67% | 1,845,000 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.45% | 0.00% | 636,244 | 215,757 | 51.31% | 1,431,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.31% | 0.00% | 3,240,379 | 195,015 | 6.40% | 7,292,316 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.30% | 0.00% | 428,554 | 80,015 | 22.96% | 964,246 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 75,441 | 75,441 | 100.00% | 169,742 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.05% | 0.00% | 74,234 | 74,234 | 100.00% | 167,027 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.11% | 0.00% | 147,720 | 67,300 | 83.69% | 332,370 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 66,707 | 66,707 | 100.00% | 150,091 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.22% | 0.00% | 315,664 | 64,216 | 25.54% | 710,244 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.85% | 0.00% | 1,193,080 | 52,074 | 4.56% | 2,684,430 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.45% | 0.00% | 7,656,890 | 50,648 | 0.67% | 17,228,002 | Jun 30, 2024 |
| POWELL INVESTMENT ADVISORS, LLC | 0.04% | 0.06% | 50,000 | 50,000 | 100.00% | 112,500 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.24% | 0.00% | 336,047 | 45,549 | 15.68% | 756,105 | Jun 30, 2024 |
| STATE STREET CORP | 2.32% | 0.00% | 3,258,633 | 43,617 | 1.36% | 7,331,924,000 | Jun 30, 2024 |
As of Jun 30 2024, Xeris Biopharma's largest institutional buyer is BIOIMPACT CAPITAL LLC. The company purchased 664.03K stocks of XERS, valued at $10.87M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | 0.16% | 0.00% | 219,906 | -733,330 | -76.93% | 494,788 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | - | - | - | -598,086 | -100.00% | - | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | - | - | - | -419,100 | -100.00% | - | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -310,959 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.96% | 0.00% | 1,342,612 | -247,890 | -15.59% | 3,020,877 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.01% | 31,782 | -223,267 | -87.54% | 71,510 | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -199,023 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.37% | 0.00% | 518,024 | -188,987 | -26.73% | 1,165,554 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -182,324 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.02% | 0.00% | 23,903 | -154,659 | -86.61% | 53,782 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.02% | 0.00% | 26,803 | -103,061 | -79.36% | 60,307 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 1.04% | 0.20% | 1,465,875 | -77,998 | -5.05% | 3,298,219 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -73,570 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -68,849 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -65,577 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.79% | 0.00% | 1,107,169 | -52,386 | -4.52% | 2,491,131,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.23% | 0.00% | 324,403 | -49,952 | -13.34% | 729,906 | Jun 30, 2024 |
| DELTEC ASSET MANAGEMENT LLC | 0.01% | 0.01% | 14,000 | -38,000 | -73.08% | 31,500 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -35,375 | -100.00% | - | Jun 30, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -34,538 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Xeris Biopharma's biggest institutional seller is AMERIPRISE FINANCIAL INC. The company sold -0.73M shares of XERS, valued at $494.79K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 75,441 | 75,441 | 100.00% | 169,742 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.05% | 0.00% | 74,234 | 74,234 | 100.00% | 167,027 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 66,707 | 66,707 | 100.00% | 150,091 | Jun 30, 2024 |
| POWELL INVESTMENT ADVISORS, LLC | 0.04% | 0.06% | 50,000 | 50,000 | 100.00% | 112,500 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.01% | - | 19,488 | 19,488 | 100.00% | 43,848 | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | 0.01% | 0.00% | 12,156 | 12,156 | 100.00% | 27,351 | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | 0.01% | 0.00% | 12,156 | 12,156 | 100.00% | 27,351 | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | 0.01% | 0.00% | 11,267 | 11,267 | 100.00% | 25,351 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | - | 4,426 | 4,426 | 100.00% | 10,003 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 1,632 | 1,632 | 100.00% | 3,672 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 2,250 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 379 | 379 | 100.00% | 853 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 125 | 125 | 100.00% | 281 | Jun 30, 2024 |
Xeris Biopharma's largest new institutional shareholder by number of shares is COREBRIDGE FINANCIAL, INC., purchased 75.44K shares, valued at $169.74K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | - | - | - | -598,086 | -100.00% | - | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | - | - | - | -419,100 | -100.00% | - | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -310,959 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -199,023 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -182,324 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -73,570 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -68,849 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -65,577 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -35,375 | -100.00% | - | Jun 30, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -34,538 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -33,589 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -28,675 | -100.00% | - | Jun 30, 2024 |
| CSS LLC/IL | - | - | - | -18,124 | -100.00% | - | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | - | - | - | -18,098 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -16,732 | -100.00% | - | Jun 30, 2024 |
| CRYSTALLINE MANAGEMENT INC. | - | - | - | -16,573 | -100.00% | - | Jun 30, 2024 |
| AMERITAS ADVISORY SERVICES, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,068 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -3,963 | -100.00% | - | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | - | - | - | -570 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -417 | -100.00% | - | Jun 30, 2024 |
| SOA WEALTH ADVISORS, LLC. | - | - | - | -118 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -27 | -100.00% | - | Jun 30, 2024 |
Xeris Biopharma's largest sold out institutional shareholder by shares sold is STONEPINE CAPITAL MANAGEMENT, LLC, sold -0.60M shares, valued at -, as of undefined.
Xeris Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| MERIDIAN FUND INC | 0.48% | 1,125,971 | - | - | Mar 28, 2024 |
| FORUM FUNDS | 0.22% | 500,000 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.17% | 393,000 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.16% | 1,322,735 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.15% | 79,815 | - | - | Mar 31, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.06% | 2,000,000 | - | - | Jan 31, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.06% | 2,000,000 | - | - | Jan 31, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.05% | 630,182 | 630,182 | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 235,709 | -17,554 | -6.93% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 20,745 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 209,399 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,696,072 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 3,592 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.02% | 300,000 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 6,373,250 | -1,718,295 | -21.24% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,895 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 67,887 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 364,382 | -631 | -0.17% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,843,475 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,306,277 | 44,775 | 3.55% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.01% | 71,750 | 42,381 | 144.31% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 935 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 266,300 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 9,930 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 78,725 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 585,336 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 76,499 | -1,759 | -2.25% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 51,700 | - | - | Feb 29, 2024 |
| VALIC Co II | 0.00% | 69,614 | - | - | Feb 28, 2021 |
| BRIDGEWAY FUNDS INC | 0.00% | 4,800 | - | - | Mar 28, 2024 |
| ProFunds | 0.00% | 21,475 | 20,355 | 1817.41% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 51,440 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 6,977 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 44,099 | -11,778 | -21.08% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 3,180 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,103 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 1,233,443 | 1,165,530 | 1716.21% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 11,801 | - | - | Mar 31, 2024 |
| JPMORGAN TRUST II | 0.00% | 910,100 | - | - | Feb 29, 2024 |
| GPS Funds I | 0.00% | 4,192 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 49,200 | 6,500 | 15.22% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 379 | - | - | Apr 30, 2021 |
| ETF Managers Trust | 0.00% | 5,428 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 8,280 | 1,551 | 23.05% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 20,975 | - | - | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 27,000 | - | - | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 5,600 | - | - | Mar 28, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 22,478 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 12,197 | 4,780 | 64.45% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 2,346 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 59,679 | - | - | Mar 28, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 35,697 | 24,726 | 225.38% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 6,297 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 613,730 | 76,483 | 14.24% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 4,970,397 | -279,042 | -5.32% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,214 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 740 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 312,192 | -13,810 | -4.24% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 77,815 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 18,732 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 25,567 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 51,065 | -206 | -0.40% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,053 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 14,566 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 21,127 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 602 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 4,300 | - | - | Mar 28, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 59,395 | 59,395 | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 4,381 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,500 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 29,814 | 3,819 | 14.69% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 344,882 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 14,139 | -91 | -0.64% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 16,090 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 374,158 | - | - | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 29,348 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 5,854 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 997 | - | - | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 26,169 | - | - | Dec 31, 2023 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 400 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,418 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 21,817 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 149,110 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 17,325 | 3,214 | 22.78% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 1,520 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 79 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 7,869 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust I | 0.00% | 421,800 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 12,950 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 43,863 | -1,844 | -4.03% | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 113,800 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4,439 | - | - | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 4,063 | -13,378 | -76.70% | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,312 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 15,075 | -61 | -0.40% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 41,464 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,476 | - | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 2,427 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 110,290 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 100,780 | - | - | Mar 31, 2024 |
Xeris Biopharma's largest mutual fund holder by % of total assets is "MERIDIAN FUND INC", owning 1.13M shares, compromising 0.48% of its total assets.
Xeris Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 135 | -7.53% |
| 31 Mar, 24 | 146 | 19.67% |
| 31 Dec, 23 | 122 | 7.02% |
| 30 Sep, 23 | 114 | 7.55% |
| 30 Jun, 23 | 106 | 12.77% |
| 31 Mar, 23 | 94 | -4.08% |
| 31 Dec, 22 | 98 | -5.77% |
| 30 Sep, 22 | 104 | - |
| 30 Jun, 22 | 104 | -2.80% |
| 31 Mar, 22 | 107 | 9.18% |
| 31 Dec, 21 | 98 | 36.11% |
| 30 Sep, 21 | 72 | -27.27% |
| 30 Jun, 21 | 99 | -5.71% |
| 31 Mar, 21 | 105 | 1.94% |
| 31 Dec, 20 | 103 | 8.42% |
| 30 Sep, 20 | 95 | 15.85% |
| 30 Jun, 20 | 82 | 24.24% |
| 31 Mar, 20 | 66 | 15.79% |
| 31 Dec, 19 | 57 | 7.55% |
| 30 Sep, 19 | 53 | 6.00% |
| 30 Jun, 19 | 50 | 2.04% |
| 31 Mar, 19 | 49 | 40.00% |
| 31 Dec, 18 | 35 | -2.78% |
| 30 Sep, 18 | 36 | 16.13% |
| 30 Jun, 18 | 31 | - |
As of 30 Jun 24, 135 institutions are holding Xeris Biopharma's shares, representing a decrease of -7.53% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 60,506,223 | -0.18% |
| 31 Mar, 24 | 60,615,681 | 1.47% |
| 31 Dec, 23 | 59,735,564 | 8.86% |
| 30 Sep, 23 | 54,874,042 | -1.62% |
| 30 Jun, 23 | 55,774,953 | 13.09% |
| 31 Mar, 23 | 49,318,037 | -8.19% |
| 31 Dec, 22 | 53,718,341 | -5.94% |
| 30 Sep, 22 | 57,109,670 | -3.44% |
| 30 Jun, 22 | 59,146,799 | 17.68% |
| 31 Mar, 22 | 50,262,820 | 23.69% |
| 31 Dec, 21 | 40,636,987 | 136.79% |
| 30 Sep, 21 | 17,161,676 | -38.66% |
| 30 Jun, 21 | 27,976,017 | -15.47% |
| 31 Mar, 21 | 33,094,214 | 29.58% |
| 31 Dec, 20 | 25,538,714 | 1.46% |
| 30 Sep, 20 | 25,170,086 | -21.27% |
| 30 Jun, 20 | 31,970,408 | 36.23% |
| 31 Mar, 20 | 23,467,983 | 33.07% |
| 31 Dec, 19 | 17,635,965 | -1.55% |
| 30 Sep, 19 | 17,914,283 | 6.23% |
| 30 Jun, 19 | 16,863,264 | 5.33% |
| 31 Mar, 19 | 16,009,804 | 48.31% |
| 31 Dec, 18 | 10,794,951 | 2.48% |
| 30 Sep, 18 | 10,534,092 | 8.39% |
| 30 Jun, 18 | 9,718,830 | - |
Xeris Biopharma (XERS) has 60.51M shares outstanding as of 30 Jun 24, down -0.18% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 43.06% | 2.31% |
| 31 Mar, 24 | 43.14% | 2.31% |
| 31 Dec, 23 | 43.25% | 2.74% |
| 30 Sep, 23 | 39.75% | 2.41% |
| 30 Jun, 23 | 40.61% | 3.14% |
| 31 Mar, 23 | 35.96% | 2.30% |
| 31 Dec, 22 | 39.50% | 2.24% |
| 30 Sep, 22 | 42.01% | 2.21% |
| 30 Jun, 22 | 43.64% | 3.15% |
| 31 Mar, 22 | 37.22% | 1.41% |
| 31 Dec, 21 | 51.42% | 7.72% |
| 30 Sep, 21 | 25.81% | 1.45% |
| 30 Jun, 21 | 42.15% | 1.44% |
| 31 Mar, 21 | 54.04% | 1.51% |
| 31 Dec, 20 | 59.89% | 2.01% |
| 30 Sep, 20 | 54.55% | 0.77% |
| 30 Jun, 20 | 84.19% | 1.64% |
| 31 Mar, 20 | 71.57% | 1.57% |
| 31 Dec, 19 | 67.54% | 1.53% |
| 30 Sep, 19 | 66.49% | 1.69% |
| 30 Jun, 19 | 62.71% | 1.36% |
| 31 Mar, 19 | 67.95% | 0.85% |
| 31 Dec, 18 | 89.61% | 1.17% |
| 30 Sep, 18 | 87.45% | 1.34% |
| 30 Jun, 18 | 80.68% | - |
As of 30 Jun 24, Xeris Biopharma is held by 43.06% institutional shareholders, representing a 2.31% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 69 | -18.82% |
| 31 Mar, 24 | 85 | 49.12% |
| 31 Dec, 23 | 57 | 9.62% |
| 30 Sep, 23 | 52 | 4.00% |
| 30 Jun, 23 | 50 | 35.14% |
| 31 Mar, 23 | 37 | -13.95% |
| 31 Dec, 22 | 43 | 13.16% |
| 30 Sep, 22 | 38 | -29.63% |
| 30 Jun, 22 | 54 | -6.90% |
| 31 Mar, 22 | 58 | -7.94% |
| 31 Dec, 21 | 63 | 103.23% |
| 30 Sep, 21 | 31 | -34.04% |
| 30 Jun, 21 | 47 | -16.07% |
| 31 Mar, 21 | 56 | - |
| 31 Dec, 20 | 56 | -5.08% |
| 30 Sep, 20 | 59 | -3.28% |
| 30 Jun, 20 | 61 | 35.56% |
| 31 Mar, 20 | 45 | 32.35% |
| 31 Dec, 19 | 34 | 6.25% |
| 30 Sep, 19 | 32 | -5.88% |
| 30 Jun, 19 | 34 | -17.07% |
| 31 Mar, 19 | 41 | 115.79% |
| 31 Dec, 18 | 19 | -36.67% |
| 30 Sep, 18 | 30 | -3.23% |
| 30 Jun, 18 | 31 | - |
69 institutional shareholders have increased their position in XERS stock as of 30 Jun 24 compared to 85 in the previous quarter (a -18.82% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 35 | 6.06% |
| 31 Mar, 24 | 33 | 6.45% |
| 31 Dec, 23 | 31 | 19.23% |
| 30 Sep, 23 | 26 | -7.14% |
| 30 Jun, 23 | 28 | 16.67% |
| 31 Mar, 23 | 24 | -11.11% |
| 31 Dec, 22 | 27 | -3.57% |
| 30 Sep, 22 | 28 | 12.00% |
| 30 Jun, 22 | 25 | - |
| 31 Mar, 22 | 25 | 47.06% |
| 31 Dec, 21 | 17 | -26.09% |
| 30 Sep, 21 | 23 | -32.35% |
| 30 Jun, 21 | 34 | 30.77% |
| 31 Mar, 21 | 26 | 4.00% |
| 31 Dec, 20 | 25 | 38.89% |
| 30 Sep, 20 | 18 | 28.57% |
| 30 Jun, 20 | 14 | 7.69% |
| 31 Mar, 20 | 13 | 30.00% |
| 31 Dec, 19 | 10 | - |
| 30 Sep, 19 | 10 | 25.00% |
| 30 Jun, 19 | 8 | 300.00% |
| 31 Mar, 19 | 2 | -77.78% |
| 31 Dec, 18 | 9 | 350.00% |
| 30 Sep, 18 | 2 | - |
| 30 Jun, 18 | - | - |
35 institutional shareholders have reduced their position in XERS stock as of 30 Jun 24 compared to 33 in the previous quarter (a 6.06% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 135 | -7.53% | 60,506,223 | -0.18% | 43.06% | 2.31% | 69 | -18.82% | 35 | 6.06% |
| 31 Mar, 24 | 146 | 19.67% | 60,615,681 | 1.47% | 43.14% | 2.31% | 85 | 49.12% | 33 | 6.45% |
| 31 Dec, 23 | 122 | 7.02% | 59,735,564 | 8.86% | 43.25% | 2.74% | 57 | 9.62% | 31 | 19.23% |
| 30 Sep, 23 | 114 | 7.55% | 54,874,042 | -1.62% | 39.75% | 2.41% | 52 | 4.00% | 26 | -7.14% |
| 30 Jun, 23 | 106 | 12.77% | 55,774,953 | 13.09% | 40.61% | 3.14% | 50 | 35.14% | 28 | 16.67% |
| 31 Mar, 23 | 94 | -4.08% | 49,318,037 | -8.19% | 35.96% | 2.30% | 37 | -13.95% | 24 | -11.11% |
| 31 Dec, 22 | 98 | -5.77% | 53,718,341 | -5.94% | 39.50% | 2.24% | 43 | 13.16% | 27 | -3.57% |
| 30 Sep, 22 | 104 | - | 57,109,670 | -3.44% | 42.01% | 2.21% | 38 | -29.63% | 28 | 12.00% |
| 30 Jun, 22 | 104 | -2.80% | 59,146,799 | 17.68% | 43.64% | 3.15% | 54 | -6.90% | 25 | - |
| 31 Mar, 22 | 107 | 9.18% | 50,262,820 | 23.69% | 37.22% | 1.41% | 58 | -7.94% | 25 | 47.06% |
| 31 Dec, 21 | 98 | 36.11% | 40,636,987 | 136.79% | 51.42% | 7.72% | 63 | 103.23% | 17 | -26.09% |
| 30 Sep, 21 | 72 | -27.27% | 17,161,676 | -38.66% | 25.81% | 1.45% | 31 | -34.04% | 23 | -32.35% |
| 30 Jun, 21 | 99 | -5.71% | 27,976,017 | -15.47% | 42.15% | 1.44% | 47 | -16.07% | 34 | 30.77% |
| 31 Mar, 21 | 105 | 1.94% | 33,094,214 | 29.58% | 54.04% | 1.51% | 56 | - | 26 | 4.00% |
| 31 Dec, 20 | 103 | 8.42% | 25,538,714 | 1.46% | 59.89% | 2.01% | 56 | -5.08% | 25 | 38.89% |
| 30 Sep, 20 | 95 | 15.85% | 25,170,086 | -21.27% | 54.55% | 0.77% | 59 | -3.28% | 18 | 28.57% |
| 30 Jun, 20 | 82 | 24.24% | 31,970,408 | 36.23% | 84.19% | 1.64% | 61 | 35.56% | 14 | 7.69% |
| 31 Mar, 20 | 66 | 15.79% | 23,467,983 | 33.07% | 71.57% | 1.57% | 45 | 32.35% | 13 | 30.00% |
| 31 Dec, 19 | 57 | 7.55% | 17,635,965 | -1.55% | 67.54% | 1.53% | 34 | 6.25% | 10 | - |
| 30 Sep, 19 | 53 | 6.00% | 17,914,283 | 6.23% | 66.49% | 1.69% | 32 | -5.88% | 10 | 25.00% |
| 30 Jun, 19 | 50 | 2.04% | 16,863,264 | 5.33% | 62.71% | 1.36% | 34 | -17.07% | 8 | 300.00% |
| 31 Mar, 19 | 49 | 40.00% | 16,009,804 | 48.31% | 67.95% | 0.85% | 41 | 115.79% | 2 | -77.78% |
| 31 Dec, 18 | 35 | -2.78% | 10,794,951 | 2.48% | 89.61% | 1.17% | 19 | -36.67% | 9 | 350.00% |
| 30 Sep, 18 | 36 | 16.13% | 10,534,092 | 8.39% | 87.45% | 1.34% | 30 | -3.23% | 2 | - |
| 30 Jun, 18 | 31 | - | 9,718,830 | - | 80.68% | - | 31 | - | - | - |
Xeris Biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Xeris Biopharma's stock was made by Hecht Beth on Aug 09 2024, selling 14,037 shares at $2.11 per share (valued at $29.62K). The last insider buy of XERS was made by Schmid John P. on Aug 13 2024, buying 4,515 shares at $2.25 per share (worth $10.15K).
Xeris Biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 6 | 4 | 150.00% |
| Q2 2024 | 9 | - | - |
| Q1 2024 | 11 | 13 | 84.62% |
| Q4 2023 | 6 | - | - |
| Q3 2023 | 1 | 1 | 100.00% |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 7 | 12 | 58.33% |
| Q4 2022 | 1 | - | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 15 | - | - |
| Q1 2022 | 7 | 10 | 70.00% |
| Q4 2021 | 104 | 61 | 170.49% |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 5 | 1 | 500.00% |
| Q1 2021 | 7 | 2 | 350.00% |
| Q4 2020 | 1 | 1 | 100.00% |
| Q3 2020 | 5 | - | - |
| Q2 2020 | 13 | - | - |
| Q1 2020 | 12 | 2 | 600.00% |
| Q4 2019 | 4 | 2 | 200.00% |
6 total buy trades, and 4 total sell trades (buy/sell ratio of 1.50%) were made by Xeris Biopharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 1 | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 6 | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 1 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 1 | - | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | 5 | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 1 | - |
| Q1 2021 | - | 2 | - |
| Q4 2020 | 1 | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 3 | - | - |
| Q1 2020 | 6 | 1 | 600.00% |
| Q4 2019 | 1 | 1 | 100.00% |
As of Q3 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Xeris Biopharma's stocks.
Xeris Biopharma Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| MCRB | Seres Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| IBRX | ImmunityBio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| CDTX | Cidara Therapeutics, Inc. |
| ELEV | Elevation Oncology, Inc. |
| GRTX | Galera Therapeutics, Inc. |
XERS Ownership FAQ
Who Owns Xeris Biopharma?
Xeris Biopharma is owned by institutional shareholders (43.06%), insiders (3.91%), and public (53.03%). The largest institutional shareholder of Xeris Biopharma is BLACKROCK INC. (7.35% of total shares) and the top mutual fund owner is MERIDIAN FUND INC (0.48% of total shares).
Who are the major institutional shareholders of Xeris Biopharma?
Xeris Biopharma's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, CAXTON CORP, BIOIMPACT CAPITAL LLC, and STATE STREET CORP. The top five shareholders own together 22.20% of the company's share outstanding.
How many Xeris Biopharma shareholders are there?
As of Jun 2024, there are 135 institutional shareholders of Xeris Biopharma.
What percentage of Xeris Biopharma is owned by BLACKROCK INC?
BLACKROCK INC owns 10.33M shares of Xeris Biopharma, representing 7.35% of the company's total shares outstanding, valued at $23.25M (as of Jun 2024).
What percentage of Xeris Biopharma is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 7.66M shares of Xeris Biopharma (XERS), compromising 5.45% of the company, valued at $17.23M.
What percentage of Xeris Biopharma is owned by CAXTON CORP?
CAXTON CORP is the third largest holder of Xeris Biopharma. The company owns 5.11M of the company's shares outstanding (worth $11.51M).